Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of gamma radiation shielding properties of hafnium dioxide thin films prepared at different molarities with using 14.9, 22.1, 32.1, 41.5 and 59.5 keV energies.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025
Same author

Patient-reported outcomes for older adults on CamAPS FX closed loop system.

Diabetic medicine : a journal of the British Diabetic Association·2023
Same author

Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Microbial detection in seroma fluid preceding the diagnosis of breast implant-associated anaplastic large cell lymphoma: a case report and review of the literature.

Case reports in plastic surgery & hand surgery·2020
Same author

Children and adolescents with type 1 and type 2 diabetes mellitus in the Pediatric Diabetes Consortium Registries: comparing clinical characteristics and glycaemic control.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Monetary reinforcement for self-monitoring of blood glucose among young people with type 1 diabetes: evaluating effects on psychosocial functioning.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same journal

Efficacy and Safety of Ion Channel Modulators in Painful Diabetic Neuropathy.

Diabetes, obesity & metabolism·2026
Same journal

Exercise Resistance in Obese Male NZO Mice Manifests as Local Muscle Remodelling Without Glycaemic Improvements.

Diabetes, obesity & metabolism·2026
Same journal

GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study.

Diabetes, obesity & metabolism·2026
Same journal

Efficacy and Safety of the Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist Mazdutide in Predominantly Chinese Adults With Obesity and/or Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Diabetes, obesity & metabolism·2026
Same journal

A Sequential Dual GLP-1R/GIPR Agonist-To-Antagonist Molecule Achieves Superior Weight Loss in Obese Mice.

Diabetes, obesity & metabolism·2026
Same journal

Efficacy and Safety of Tubeless Hybrid Closed-Loop Systems in Type 1 Diabetes: A Meta-Analysis of Randomized Controlled Trials.

Diabetes, obesity & metabolism·2026
See all related articles

Related Experiment Videos

Incentivizing behaviour change to improve diabetes care.

N M Petry1, E Cengiz, J A Wagner

  • 1Calhoun Cardiology Center and Department of Medicine, University of Connecticut School of Medicine, Farmington, CT, USA.

Diabetes, Obesity & Metabolism
|April 12, 2013
PubMed
Summary
This summary is machine-generated.

Behavioural economics uses incentives to encourage healthy behaviors in healthcare. Reinforcement interventions show success in diabetes prevention and management, improving adherence and monitoring.

Keywords:
behavioural economicsdiabetesincentivesreinforcement

Related Experiment Videos

Area of Science:

  • Behavioral Economics
  • Health Psychology
  • Health Behavior Interventions

Background:

  • Behavioral economics studies psychological and cognitive factors influencing decision-making.
  • This field is increasingly applied in healthcare, utilizing incentives for healthy lifestyle behaviors.

Purpose of the Study:

  • To review the background and efficacy of reinforcement interventions in general.
  • To examine the application of these interventions in diabetes prevention and management.

Main Methods:

  • Review of existing literature on reinforcement interventions.
  • Analysis of applications in diabetes-related behaviors such as appointment attendance, weight loss, exercise, medication adherence, and blood glucose monitoring.

Main Results:

  • Reinforcement interventions have demonstrated notable success in promoting healthy behaviors.
  • Specific successes include improved medical appointment attendance, weight loss, exercise, medication adherence, and blood glucose monitoring in diabetes care.

Conclusions:

  • Reinforcement interventions are effective tools for behavior change in healthcare settings.
  • Further research into promising areas is suggested, acknowledging the controversial nature of these interventions.